Cyramza 10 mg/ml concentrate for solution for infusion, PACLITAXEL AHCL 6 mg/ml, solution à diluer pour perfusion clinical trials

PRODIGE 55-SOCRATE : A randomized phase II study to evaluate second-line ramucirumab alone or with paclitaxel in older patients with advanced gastric cancer

This study is looking at new ways to treat advanced stomach cancer in older patients. It compares two treatments, ramucirumab alone or with paclitaxel, to see which helps people live longer and have a better quality of life.